Pharmacogenomics is the study of how genes affect a person’s response to drugs. In the modern era of medicine, pharmacogenomics study can overcome problems in modern medicine such as avoid life-threatening adverse drug reactions, avoid the drug not working with the patients and make a correct drug selection and the right dose adjustment.
Our research:

•       Candidate gene study of Anti-tuberculosis  drug induced-liver injury (AT-DILI)

•       Meta-analysis of NAT2 slow-acetylator

•       Candidate gene study of drug-induced SJS/TEN and other Severe-cutaneous Adverse Reaction